RESEARCH PROJECTS

Problem solver

HYPOSTAT Study CyberKnife

With the help of the “BEYOND CANCER RESEARCH” fund by Dr. Rurainski Foundation, the first HYPOSTAT study was carried out in 2019/2020. It was the first and so far only study in Germany to deal with a new form of short-term, high-dose radiosurgery using a robot-assisted linear accelerator for the treatment of prostate cancer.

BEYOND CANCER RESEARCH PROJECT 2019/2020

Best Practice in Cancer Therapy

Treatment of prostate cancer with robotic hypofractionated radiosurgery using CyberKnife

Leading Cancer Researcher Prof. Dr. Dunst

"With the support of Dr. Rurainski Foundation, we were able to collect enough data to prove that hypofractionated radiosurgery can be an integral part of the treatment of prostate tumors. In our HYPOSTAT study, all patients were very satisfied with the treatment results. As expected, the side effects were low, with a good response to the tumor disease."

Prof. Dr. Jürgen Dunst

Director of the Clinic for Radiation Therapy at UKSH and the Medical Faculty of Christian-Albrechts-Universität zu Kiel (CAU) and HYPOSTAT study director, Lübeck

RESEARCH PROJECTS

HYPOSTAT Study CyberKnife

Best Practice in Cancer Therapy

Treatment of prostate cancer with robotic hypofractionated radiosurgery using CyberKnife

FOUNDATION

NAVIGATION

QUICK LINKS

Join our newsletter and get 20% discount